These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16903453)

  • 1. Values and beliefs of psychedelic drug users: a cross-cultural study.
    Lerner M; Lyvers M
    J Psychoactive Drugs; 2006 Jun; 38(2):143-7. PubMed ID: 16903453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M; Meester M
    J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voice of the psychonauts: coping, life purpose, and spirituality in psychedelic drug users.
    Móró L; Simon K; Bárd I; Rácz J
    J Psychoactive Drugs; 2011; 43(3):188-98. PubMed ID: 22111402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.
    Griffiths RR; Hurwitz ES; Davis AK; Johnson MW; Jesse R
    PLoS One; 2019; 14(4):e0214377. PubMed ID: 31013281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescents' beliefs about future substance use: a comparison of current users and non-users of cigarettes, alcohol and illicit drugs.
    Sutherland I; Shepherd JP
    J Adolesc; 2002 Apr; 25(2):169-81. PubMed ID: 12069433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.
    Sweeney MM; Nayak S; Hurwitz ES; Mitchell LN; Swift TC; Griffiths RR
    PLoS One; 2022; 17(8):e0271926. PubMed ID: 36001643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of psychedelic use and opioid use disorders among illicit users in the United States.
    Pisano VD; Putnam NP; Kramer HM; Franciotti KJ; Halpern JH; Holden SC
    J Psychopharmacol; 2017 May; 31(5):606-613. PubMed ID: 28196428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging psychoactive substance use among regular ecstasy users in Australia.
    Bruno R; Matthews AJ; Dunn M; Alati R; McIlwraith F; Hickey S; Burns L; Sindicich N
    Drug Alcohol Depend; 2012 Jul; 124(1-2):19-25. PubMed ID: 22209387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
    Sumnall HR; Cole JC; Jerome L
    J Psychopharmacol; 2006 Sep; 20(5):670-82. PubMed ID: 16401654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.
    Révész D; Ona G; Rossi GN; Rocha JM; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
    Front Psychiatry; 2021; 12():687546. PubMed ID: 34220590
    [No Abstract]   [Full Text] [Related]  

  • 11. The HIT clinical profile of psychedelic drug users.
    Hartung J; Skorka D
    J Pers Assess; 1980 Jun; 44(3):237-45. PubMed ID: 7391921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.
    Sweat NW; Bates LW; Hendricks PS
    J Psychoactive Drugs; 2016; 48(5):344-350. PubMed ID: 27719438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why psychiatry needs psychedelics and psychedelics need psychiatry.
    Sessa B
    J Psychoactive Drugs; 2014; 46(1):57-62. PubMed ID: 24830186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.
    Kangaslampi S; Hausen A; Rauteenmaa T
    J Psychoactive Drugs; 2020; 52(4):309-318. PubMed ID: 32511073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective effects of Salvia divinorum: LSD- or marijuana-like?
    Albertson DN; Grubbs LE
    J Psychoactive Drugs; 2009 Sep; 41(3):213-7. PubMed ID: 19999674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.
    Riley S; Thompson J; Griffin C
    Int J Drug Policy; 2010 Nov; 21(6):445-51. PubMed ID: 20810266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Gratuitous Grace: The Influence of Religious Set and Intent on the Psychedelic Experience.
    Neitzke-Spruill L; Glasser C
    J Psychoactive Drugs; 2018; 50(4):314-321. PubMed ID: 30052496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Emotion regulation among psychostimulants drug users at techno parties].
    Lillaz C; Varescon I
    Encephale; 2012 Oct; 38(5):390-6. PubMed ID: 23062452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives.
    Cox DJ; Garcia-Romeu A; Johnson MW
    Am J Drug Alcohol Abuse; 2021 Jul; 47(4):444-454. PubMed ID: 34096403
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral health status of a group of illicit drug users in Delhi, India.
    Gupta T; Shah N; Mathur VP; Dhawan A
    Community Dent Health; 2012 Mar; 29(1):49-54. PubMed ID: 22482250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.